Edwards Lifesciences Corp Stock Price History
EW Stock | USD 71.35 0.72 1.00% |
Below is the normalized historical share price chart for Edwards Lifesciences Corp extending back to March 27, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Edwards Lifesciences stands at 71.35, as last reported on the 30th of November, with the highest price reaching 71.71 and the lowest price hitting 70.23 during the day.
If you're considering investing in Edwards Stock, it is important to understand the factors that can impact its price. At this stage we consider Edwards Stock to be very steady. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of 0.0452, which denotes the company had a 0.0452% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Edwards Lifesciences Corp, which you can use to evaluate the volatility of the firm. Please confirm Edwards Lifesciences' Coefficient Of Variation of 2229.89, mean deviation of 1.17, and Downside Deviation of 1.5 to check if the risk estimate we provide is consistent with the expected return of 0.071%.
At this time, Edwards Lifesciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 9.8 B in 2024, despite the fact that Other Stockholder Equity is likely to grow to (2.6 B). . At this time, Edwards Lifesciences' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to climb to 77.16 in 2024, whereas Price Earnings Ratio is likely to drop 31.34 in 2024. Edwards Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of March 2000 | 200 Day MA 79.4129 | 50 Day MA 67.9142 | Beta 1.12 |
Edwards |
Sharpe Ratio = 0.0452
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | EW | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.57 actual daily | 13 87% of assets are more volatile |
Expected Return
0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Edwards Lifesciences is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.
Price Book 4.453 | Enterprise Value Ebitda 21.9982 | Price Sales 6.664 | Shares Float 583.8 M | Wall Street Target Price 76.605 |
Edwards Lifesciences Stock Price History Chart
There are several ways to analyze Edwards Stock price data. The simplest method is using a basic Edwards candlestick price chart, which shows Edwards Lifesciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 27, 2024 | 72.07 |
Lowest Price | October 7, 2024 | 64.54 |
Edwards Lifesciences November 30, 2024 Stock Price Synopsis
Various analyses of Edwards Lifesciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Edwards Stock. It can be used to describe the percentage change in the price of Edwards Lifesciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Edwards Stock.Edwards Lifesciences Price Daily Balance Of Power | (0.49) | |
Edwards Lifesciences Price Action Indicator | 0.02 | |
Edwards Lifesciences Price Rate Of Daily Change | 0.99 | |
Edwards Lifesciences Accumulation Distribution | 43,877 |
Edwards Lifesciences November 30, 2024 Stock Price Analysis
Edwards Stock Price History Data
The price series of Edwards Lifesciences for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 7.53 with a coefficient of variation of 2.73. Under current investment horizon, the daily prices are spread out with arithmetic mean of 68.0. The median price for the last 90 days is 68.13. The company completed 3:1 stock split on 1st of June 2020.Open | High | Low | Close | Volume | ||
11/29/2024 | 71.57 | 71.71 | 70.23 | 71.35 | 2,125,966 | |
11/27/2024 | 71.32 | 72.63 | 71.32 | 72.07 | 2,753,319 | |
11/26/2024 | 71.50 | 72.44 | 70.76 | 71.55 | 4,643,382 | |
11/25/2024 | 71.00 | 71.41 | 70.15 | 71.27 | 6,645,296 | |
11/22/2024 | 70.31 | 71.00 | 69.96 | 70.48 | 2,711,629 | |
11/21/2024 | 69.65 | 70.88 | 69.16 | 70.38 | 3,734,694 | |
11/20/2024 | 70.55 | 70.61 | 68.45 | 69.54 | 4,305,475 | |
11/19/2024 | 69.15 | 70.26 | 68.30 | 70.20 | 4,914,609 | |
11/18/2024 | 67.63 | 71.08 | 67.58 | 69.89 | 7,061,282 | |
11/15/2024 | 65.31 | 67.83 | 65.31 | 67.76 | 7,530,061 | |
11/14/2024 | 66.39 | 67.68 | 65.83 | 66.16 | 4,005,607 | |
11/13/2024 | 65.82 | 66.89 | 65.31 | 66.52 | 3,655,784 | |
11/12/2024 | 66.50 | 66.79 | 64.89 | 65.81 | 5,087,779 | |
11/11/2024 | 66.42 | 67.09 | 66.35 | 66.70 | 5,600,365 | |
11/08/2024 | 66.33 | 66.78 | 65.48 | 66.23 | 3,088,428 | |
11/07/2024 | 66.02 | 66.33 | 65.26 | 65.84 | 3,856,412 | |
11/06/2024 | 68.27 | 68.27 | 65.61 | 65.75 | 5,339,652 | |
11/05/2024 | 66.17 | 66.72 | 65.51 | 66.69 | 3,821,733 | |
11/04/2024 | 67.62 | 67.84 | 66.18 | 66.47 | 3,970,717 | |
11/01/2024 | 67.16 | 68.58 | 66.67 | 67.54 | 4,040,799 | |
10/31/2024 | 68.37 | 68.37 | 67.00 | 67.01 | 6,306,939 | |
10/30/2024 | 68.52 | 70.65 | 66.15 | 68.63 | 8,123,038 | |
10/29/2024 | 68.63 | 71.10 | 68.59 | 69.37 | 6,295,533 | |
10/28/2024 | 70.00 | 72.15 | 66.93 | 68.52 | 8,899,499 | |
10/25/2024 | 68.88 | 70.49 | 68.07 | 69.38 | 8,171,661 | |
10/24/2024 | 71.00 | 71.58 | 70.15 | 70.35 | 6,739,226 | |
10/23/2024 | 68.87 | 70.68 | 68.87 | 70.61 | 5,358,768 | |
10/22/2024 | 69.89 | 70.01 | 69.14 | 69.24 | 3,338,948 | |
10/21/2024 | 70.00 | 70.24 | 69.15 | 70.05 | 3,842,990 | |
10/18/2024 | 68.84 | 70.42 | 68.59 | 70.27 | 5,424,803 | |
10/17/2024 | 68.80 | 69.15 | 68.19 | 68.47 | 2,989,705 | |
10/16/2024 | 68.73 | 68.73 | 67.65 | 68.30 | 3,786,253 | |
10/15/2024 | 69.47 | 69.80 | 68.77 | 68.90 | 4,023,846 | |
10/14/2024 | 68.71 | 69.79 | 68.37 | 69.63 | 5,919,403 | |
10/11/2024 | 68.44 | 69.64 | 67.96 | 68.13 | 4,185,883 | |
10/10/2024 | 67.65 | 68.52 | 67.59 | 68.26 | 2,872,015 | |
10/09/2024 | 68.72 | 69.02 | 67.75 | 68.02 | 4,744,140 | |
10/08/2024 | 64.82 | 68.89 | 64.51 | 68.54 | 10,541,647 | |
10/07/2024 | 65.05 | 65.19 | 64.01 | 64.54 | 3,567,219 | |
10/04/2024 | 65.79 | 65.83 | 64.05 | 65.49 | 5,959,673 | |
10/03/2024 | 64.86 | 66.04 | 64.08 | 65.37 | 6,050,063 | |
10/02/2024 | 64.91 | 65.77 | 64.56 | 65.15 | 10,919,046 | |
10/01/2024 | 66.08 | 66.32 | 64.99 | 65.10 | 5,786,588 | |
09/30/2024 | 66.18 | 66.75 | 65.20 | 65.99 | 7,310,895 | |
09/27/2024 | 66.20 | 67.32 | 65.85 | 66.58 | 5,166,960 | |
09/26/2024 | 65.96 | 66.00 | 64.54 | 65.77 | 11,259,594 | |
09/25/2024 | 66.51 | 66.82 | 65.09 | 65.41 | 8,737,278 | |
09/24/2024 | 67.19 | 67.30 | 66.14 | 66.33 | 6,242,554 | |
09/23/2024 | 66.83 | 67.77 | 66.52 | 67.36 | 6,250,356 | |
09/20/2024 | 66.88 | 67.67 | 66.38 | 66.83 | 10,862,809 | |
09/19/2024 | 68.85 | 69.08 | 67.14 | 67.26 | 7,114,323 | |
09/18/2024 | 66.95 | 68.70 | 65.50 | 67.53 | 9,585,632 | |
09/17/2024 | 69.11 | 71.70 | 66.69 | 67.23 | 11,849,108 | |
09/16/2024 | 68.64 | 71.07 | 68.64 | 69.36 | 8,729,221 | |
09/13/2024 | 68.04 | 70.43 | 67.72 | 68.52 | 11,862,885 | |
09/12/2024 | 68.11 | 68.43 | 66.74 | 68.13 | 4,446,684 | |
09/11/2024 | 67.00 | 68.40 | 66.16 | 68.25 | 4,314,357 | |
09/10/2024 | 65.55 | 67.30 | 65.54 | 67.14 | 5,696,712 | |
09/09/2024 | 67.17 | 67.41 | 65.50 | 65.71 | 6,409,497 | |
09/06/2024 | 66.23 | 67.04 | 65.47 | 66.81 | 8,174,836 | |
09/05/2024 | 68.81 | 69.10 | 64.70 | 66.02 | 10,225,804 |
About Edwards Lifesciences Stock history
Edwards Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Edwards is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Edwards Lifesciences Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Edwards Lifesciences stock prices may prove useful in developing a viable investing in Edwards Lifesciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 609.4 M | 550.8 M | |
Net Income Applicable To Common Shares | 1.8 B | 1.8 B |
Edwards Lifesciences Quarterly Net Working Capital |
|
Edwards Lifesciences Stock Technical Analysis
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Edwards Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Edwards Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Edwards Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Edwards to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0394 | |||
Jensen Alpha | 0.0354 | |||
Total Risk Alpha | (0.20) | |||
Sortino Ratio | (0.04) | |||
Treynor Ratio | 0.3075 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.